SAFE Note vs. Convertible Note for Startups: Which One You Should Actually Use

Y Combinator invented the SAFE in 2013 because convertible notes were annoying. Not broken, exactly, but annoying: interest rates, maturity dates, legal complexity, and the general vibe of lending money to a company that didn't have any. The SAFE note vs. convertible note choice for startups didn't exist yet because there was only one option. Priced equity rounds were even worse, running up $15,000 to $40,000 in attorney fees. The SAFE stripped all of that away: no debt, no interest, no deadline, no repayment obligation. Just a contract that says "give me money now, get equity later."

Thirteen years later, the results are decisive. Carta's platform data from Q1 2025 shows SAFEs at a record 90% of all pre-seed deals. At the seed stage, where priced rounds are also an option, SAFEs still dominate at 64% compared to just 27% for priced equity and 10% for convertible notes. The post-money SAFE with a valuation cap and no discount has become the default configuration, used in 61% of all SAFE agreements in 2025.

So why does anyone still use convertible notes? Because for about 10% of raises, they're the better tool. The rest of this article explains which camp you're in, what the terms mean in plain language, and how to avoid the cap table mistakes that cost founders 5 to 15 percentage points of ownership they didn't realize they were giving away.

What Is a SAFE Note?

A SAFE is a contract between a founder and an investor. The investor hands over cash. In return, the investor gets the right to receive equity at a future date, typically when the startup raises a priced round (Series A). The SAFE is not a loan. It doesn't accrue interest. It doesn't have a maturity date. It doesn't need to be repaid if the company fails. It sits on the balance sheet as a convertible security, not as debt, which means it creates no monthly payment obligations and triggers no repayment clauses if the company dissolves before raising again. Y Combinator publishes standardized SAFE templates for free on its website, and most early-stage attorneys can execute one in a few days for $2,000 to $5,000 in legal fees.

What Is a Convertible Note?

A convertible note is a loan that converts into equity. The investor hands over cash structured as debt with an interest rate (typically 2% to 8% annually), a maturity date (usually 18 to 24 months), and a conversion mechanism that transforms the principal plus accrued interest into preferred stock when a qualifying financing event occurs. If no qualifying event happens before the maturity date, the company technically owes the investor their money back, plus interest. In practice, most investors agree to extend the maturity rather than demand repayment from a pre-revenue startup. But "in practice" and "legally obligated" are very different things, and that gap is where convertible note horror stories live.

What Are the Key Differences Between SAFE Notes and Convertible Notes?

Most comparison articles list twelve or fifteen differences between SAFEs and convertible notes. Most of those differences are technical footnotes. Here are the five that will affect your raise, your cap table, and your stress level.

Does it matter that convertible notes are legally debt?

Yes. Convertible notes are legally debt. This means they appear as liabilities on your balance sheet, and that can create problems in ways founders rarely anticipate. Some banks won't extend credit lines to companies carrying convertible debt. Future investors running due diligence may flag the debt overhang as a concern. And in a dissolution scenario, convertible noteholders are creditors who get paid before equity holders, which can create misaligned incentives between your earliest backers and everyone who comes after them. SAFEs avoid all of this. Because they're classified as convertible securities rather than debt instruments, they don't create liabilities, don't interfere with bank lending, and don't give early investors a creditor's claim on company assets.

How does interest accrual affect startup dilution?

A convertible note with a 6% interest rate and a 24-month maturity turns a $200,000 investment into $224,000 at conversion time (convertible notes use simple interest, not compound). That extra $24,000 converts into equity alongside the principal, meaning the investor gets more shares than the face value of their check would suggest. On a $5 million valuation cap, that's roughly an extra half-percent of your company that you gave away to a calendar, not to performance or additional value creation. Multiply this across three or four note holders over two years, and interest accrual can add 1 to 2 percentage points of unexpected dilution at Series A. SAFEs eliminate this entirely: no interest means the conversion amount equals exactly what the investor put in.

Why are maturity dates dangerous for founders?

The typical convertible note maturity is 18 to 24 months. The average time between a seed round and a Series A in 2026 has stretched to 616 days, according to Pitchwise's analysis. Do the math: an 18-month maturity expires at roughly 540 days, which means the average startup will hit its maturity date while still two to three months away from closing its next round. When a note matures, the investor technically has the right to demand repayment. Even though most investors extend rather than call the note, the founder is now negotiating that extension from a position of weakness. SAFEs have no maturity date. They sit quietly until a triggering event occurs, whether that's in 12 months or 36 months.

How much faster and cheaper are SAFEs to close?

A SAFE round can close in days. The documents are standardized, most attorneys have templates ready, and negotiation usually covers just two terms: the valuation cap and whether there's a discount. Total legal costs for a SAFE round typically run $2,000 to $5,000. A convertible note round takes two to four weeks minimum. The interest rate, maturity date, qualified financing threshold, conversion mechanics, and dissolution provisions all need to be negotiated separately. Total cost climbs past $7,500 once you factor in additional negotiation time and back-and-forth between counsel. For a founder who needs to close funding in 30 days to avoid running out of cash, those extra weeks of negotiation can be existential.

How do SAFEs and convertible notes differ on cap table complexity?

Each convertible note in a round can carry different terms: different caps, different discounts, different interest rates, different maturity dates. A founder takes a $100,000 note at a $5 million cap, then another $100,000 at a $6 million cap, then a third at $5.5 million cap. By Series A, $300,000 plus interest is converting at three different valuations, creating a cap table that requires a spreadsheet and a prayer. The post-money SAFE structure (introduced by YC in 2018) provides something convertible notes don't: fixed ownership percentages at signing. When you issue a post-money SAFE with a $10 million cap in exchange for a $1 million investment, the investor owns exactly 10% on a post-money basis. That math doesn't change. The tradeoff is that each new SAFE dilutes the founder's pool specifically (not earlier SAFE holders), so stacking multiple SAFEs without modeling the cumulative dilution is one of the most common and most expensive mistakes founders make.

When Should a Startup Use a SAFE?

If you're raising a pre-seed or seed round under $4 million from angels, accelerators, or early-stage funds, use a SAFE. This isn't a controversial opinion; it's what 90% of the market is already doing. SAFEs make the most sense when your company is pre-revenue and can't support a credible valuation discussion, when you want to close individual checks as commitments come in rather than coordinating a simultaneous close, when you don't want debt on your balance sheet, and when your investors already work with SAFEs regularly.

The standard configuration in 2026 is a post-money SAFE with a valuation cap and no discount. Median caps for non-AI startups sit at $6 million to $10 million at pre-seed and $10 million to $15 million at seed, according to aggregated data from Carta, PitchBook, and AngelList. AI startups command a significant premium: $12 million to $25 million at pre-seed and $25 million to $50 million or higher at seed. If you're still in the early stages of figuring out whether your idea has legs, you should probably validate the business idea before worrying about instrument type.

When Should a Startup Use a Convertible Note?

That remaining 10% of deals using convertible notes isn't random. There are specific situations where notes are the right instrument.

Bridge rounds between priced rounds. If you've already raised a Series A at a known valuation and need $500,000 to $1 million to extend your runway before Series B, a convertible note makes sense. You have a recent valuation to anchor the cap, the maturity date aligns with your Series B timeline, and the debt structure provides appropriate investor protections for what is, mechanically, a short-term loan.

Biotech, energy, and hardware companies with longer development cycles. Carta's data shows that industries like energy, biotech/pharma, and medical devices have the highest representation of convertible notes among pre-seed instruments. These sectors often involve regulatory timelines that make triggering events (priced rounds) less predictable, and institutional investors in these spaces have more experience structuring and managing debt instruments.

Investor insistence. Some angel investors, particularly those with finance or real estate backgrounds, prefer convertible notes because they understand debt instruments intuitively. If a check writer you badly want insists on a note, and the terms are reasonable (sub-8% interest, 24-month-plus maturity, standard 20% discount), it's usually not worth losing the investor over the instrument type. Just make sure all notes in the same round carry the same terms to avoid cap table chaos.

Situations requiring repayment options. In rare cases, both parties may prefer the optionality of a debt instrument that could be repaid in cash rather than converted to equity. This sometimes applies to family-and-friends rounds where the relationship dynamics make a clean repayment preferable to an ongoing equity stake.

How Does the Valuation Cap Affect Startup Dilution?

Whether you use a SAFE or a convertible note, the valuation cap is the single most consequential number you'll negotiate, and it's where the most equity gets destroyed through miscalculation.

The cap sets the maximum valuation at which the investor's money converts to equity. Set it too low, and you're giving away significantly more ownership than the check size warrants. Set it too high, and investors walk away because there's not enough upside to justify the early-stage risk.

Here's a scenario that plays out constantly: a founder raises $750,000 on SAFEs at a $4 million cap. Eighteen months later, they raise a Series A at $15 million pre-money. The SAFE holders convert at the $4 million cap, meaning they get 18.75% of the company for $750,000. If the cap had been $8 million (double the original cap), SAFE dilution would have been 9.375% instead. That difference, more than nine percentage points of the company, was determined entirely by a number the founder agreed to before they had any bargaining power.

The general rule: set your cap at 1.5 to 2 times your current implied valuation to leave room for growth without excessive dilution at conversion. And model every scenario before signing.

How Much Dilution Do SAFEs and Convertible Notes Actually Cause?

Here's a worked example using 2026 market medians. A SaaS startup raises $500,000 via a post-money SAFE with a $10 million cap. The founders own 100% before the raise. After the SAFE, investors have a contractual right to 5% ($500,000 divided by $10 million). No shares are issued yet.

Twelve months later, the startup raises a $3 million seed round at a $16 million pre-money valuation (Carta's median as of Q3 2025). The SAFE converts, the seed round dilutes everyone, and the founders end up owning roughly 60 to 65%, depending on the option pool.

Now run the same scenario with a convertible note at the same $10 million cap, carrying 6% interest over 12 months. The note converts $530,000 instead of $500,000, giving the investor 5.3% instead of 5%. On a single note, that 0.3 percentage point difference looks trivial. It stops looking trivial at scale. A startup that raises $2 million across four notes at a $10 million cap over the course of several months, each carrying 6% interest, will see $100,000 to $180,000 in accrued interest convert alongside the principal. That interest alone dilutes founders by one to two additional percentage points. The cumulative gap between a SAFE round and a note round can reach 3 to 5 percentage points of the company.

What Are the Biggest Mistakes Founders Make with SAFEs and Convertible Notes?

Stacking without modeling. This is the number-one error. Every additional SAFE or note dilutes the founder pool, and the dilution compounds in ways that aren't intuitive. Before issuing your third or fourth instrument, build a conversion model showing your ownership at every realistic Series A valuation between $8 million and $30 million. If the results surprise you, stop issuing.

Treating the cap as a valuation. The valuation cap is not your company's valuation. It's the maximum price at which an investor's money converts. Setting a cap at $5 million doesn't mean your company is worth $5 million. But here's the trap: future investors will treat it as a signal of how you valued yourself.

Ignoring total SAFE dilution across all instruments. The standard advice is to keep total dilution from all SAFEs below 20 to 25% before a priced round. If you've raised $2 million across four SAFEs at varying caps, and the cumulative dilution at your expected Series A valuation exceeds 25%, you've given away too much of the company before the growth stage even starts.

Accepting convertible note maturity dates shorter than your realistic fundraising timeline. If your plan is to raise Series A in 18 months, your note should mature at 24 to 30 months minimum. Anything shorter puts you in a position where the note matures while you're still three to six months from closing.

Not standardizing terms across investors in the same round. Every investor in a single round should get the same cap, the same discount, and (for notes) the same interest rate and maturity date. Mixed terms create cap table complexity that costs real money in legal and accounting fees at Series A. When you're starting the business, getting the legal foundation right early prevents expensive corrections later.

What Do Startup Funding Terms Look Like in 2026?

The median U.S. seed round sits at approximately $3.1 million, with a median pre-money valuation of $16 million (Carta). AI startups command a 42% premium on valuations. But the market is bifurcating: seed deal counts dropped 28% year-over-year in Q1 2025 while valuations rose 18%. Fewer companies are raising, but the ones that do are raising at higher prices. Investors now demand $300,000 to $500,000 in ARR at seed (a bar that used to be a Series A requirement), and the median wait between seed and Series A has stretched past 600 days.

For a first-time founder, the playbook is simple: use a post-money SAFE with a valuation cap benchmarked to your category (non-AI: $6 million to $10 million at pre-seed, $10 million to $15 million at seed; AI: roughly double). Close checks as they come in. Model your dilution before every new instrument. And build enough traction during the SAFE period that your Series A valuation creates a healthy step-up, because the median seed-to-Series-A valuation jump has recovered to 2.6x in 2025.

The SAFE vs. convertible note question has a default answer, and the default is SAFE. The only question worth spending time on is whether your situation falls into the 10% where a note makes more sense. If you're raising under $4 million from angels or early-stage funds, using a standard instrument your investors already understand: just use a SAFE. Spend the time you'd have spent negotiating note terms on understanding how investment works from the other side of the table.

Frequently Asked Questions

What percentage of startup deals use SAFEs vs convertible notes in 2026?

SAFEs account for 90% of pre-seed deals and 64% of seed rounds, according to Carta's Q1 2025 platform data. Convertible notes have dropped to approximately 10% of early-stage deals. The post-money SAFE with a valuation cap and no discount is the most common configuration, used in 61% of all SAFE agreements.

How much do SAFEs cost in legal fees compared to convertible notes?

A SAFE round typically costs $2,000 to $5,000 in legal fees and can close in days using Y Combinator's standardized templates. A convertible note round costs $5,000 to $7,500 or more and takes two to four weeks minimum due to additional terms that require negotiation: interest rate, maturity date, qualified financing threshold, and dissolution provisions.

Can a startup use both SAFEs and convertible notes in the same round?

It's technically possible but strongly discouraged. Mixing instrument types in the same round creates significant cap table complexity because each instrument converts on different terms, different timelines, and with different economic implications. Standardize on one instrument per round with identical terms for all investors.

What is a typical valuation cap for a pre-seed SAFE in 2026?

Median valuation caps for non-AI startups sit at $6 million to $10 million at pre-seed and $10 million to $15 million at seed, according to aggregated data from Carta, PitchBook, and AngelList. AI startups command a significant premium: $12 million to $25 million at pre-seed and $25 million to $50 million or higher at seed.

What happens if a startup fails before a SAFE converts?

SAFE holders receive nothing. Because a SAFE is not debt, there is no repayment obligation. The investor's cash is gone. With a convertible note, the investor is technically a creditor and has a legal claim on remaining company assets before equity holders, though in practice most failed startups have no assets to distribute.